IDH1 and glioblastoma: Across the GBM tumor, IDH1 was differentially expressed, with higher levels observed in the cellular tumor (6.2 ± 0.69) and lower levels in the leading edge (4.85 ± 0.66; p-values < 0.05; Table S3).